Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02233270 · ClinicalTrials.gov registry record
Pilot of AbStats /AEGIS System for Detecting Motility Abnormalities
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 10
- Enrollment target
NCT02233270: Completed study, sponsored by Cedars-Sinai Medical Center.
NCT02233270 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02233270 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
When compared to existing analyses: manometry, Smart Pill and lactulose breath testing, external Acoustic Esophago-Gastro-Intestinal Surveillance (AEGIS) may identify unique audible patterns characteristic of features of gastroinestinal (GI) motility, gastric and small bowel contractions and emptying and small intestinal bacterial overgrowth (SIBO). This research study is designed to test the capabilities of AbStats/AEGIS to identify and associate symptoms and traditional diagnostics with sound readings and correlate this data with treatment outcomes and successes in standard of care.
Primary Outcome
Acoustic readings would be recorded concurrent with standard of care diagnostics. There is no study follow up. Any patient follow up would be solely clinical standard of care, independent of study data or findings.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-10 |
What the finished NCT02233270 record still lists
NCT02233270 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02233270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02233270 about?
NCT02233270 is a clinical study titled "Pilot of AbStats /AEGIS System for Detecting Motility Abnormalities". When compared to existing analyses: manometry, Smart Pill and lactulose breath testing, external Acoustic Esophago-Gastro-Intestinal Surveillance (AEGIS) may identify unique audible patterns characteristic of features of gastroinestinal (GI) motility, gastric and small bowel contractions and emptyin...
What is the current status of trial NCT02233270?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2013-07. Estimated completion is 2014-10.
Who is sponsoring clinical trial NCT02233270?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia